[OS2-10A-4] Efficacy of yttrium-90 ibritumomab tiuxetan for early relapsed/refractory indolent B-cell lymphoma
Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.